ClinicalTrials.govpublic full text
Efficacy and Safety of Pirfenidone in CTD-ILD
pirfenidone, connective tissue diseases, interstitial lung disease, connective tissue disease, rheumatoid arthritis, systemic sclerosis, inflammatory myopathy, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 905756
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.